UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Pathways: Understanding the Role of Rad52 in Homologous Recombination for Therapeutic Advancement

Clinical cancer research, 2012-12, Vol.18 (23), p.6400-6406

2012

Volltextzugriff (PDF)

Target engagement imaging of PARP inhibitors in small-cell lung cancer

Nature communications, 2018-01, Vol.9 (1), p.176-13, Article 176

2018

Volltextzugriff (PDF)

Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications

Current oncology (Toronto), 2024-01, Vol.31 (1), p.482-500

2024

Volltextzugriff (PDF)

Radiation Therapy in the Molecular Era of Lung Cancer: How Best to Integrate Targeted Therapeutics With Definitive Radiation Therapy for Epidermal Growth Factor Receptor-Mutant Unresectable Stage III Non-Small Cell Lung Cancer?

International journal of radiation oncology, biology, physics, 2023-09, Vol.117 (1), p.115-117

Lok, Benjamin H

2023

Volltextzugriff (PDF)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer

Frontiers in oncology, 2020-11, Vol.10, p.1783-1783

2020

Volltextzugriff (PDF)

Limited-Stage Small-Cell Lung Cancer: Current Progress and the Next Frontier

Radiation (Multidisciplinary Digital Publishing Institute), 2021-12, Vol.1 (4), p.317-333

2021

Volltextzugriff (PDF)

Unravelling the biology of SCLC: implications for therapy

Nature reviews. Clinical oncology, 2017-09, Vol.14 (9), p.549-561

2017

Volltextzugriff (PDF)

PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes

Expert review of anticancer therapy, 2024-10, Vol.24 (10), p.989-1008

2024

Volltextzugriff (PDF)

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol

BMC palliative care, 2024-09, Vol.23 (1), p.223-15, Article 223

2024

Volltextzugriff (PDF)

Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer

Advances in radiation oncology, 2017-10, Vol.2 (4), p.548-554

2017

Volltextzugriff (PDF)

Intensity-Modulated Radiation Therapy in Oropharyngeal Carcinoma: Effect of Tumor Volume on Clinical Outcomes

International journal of radiation oncology, biology, physics, 2012-04, Vol.82 (5), p.1851-1857

2012

Volltextzugriff (PDF)

PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches

Journal of thoracic disease, 2020-10, Vol.12 (10), p.6240-6252

2020

Volltextzugriff (PDF)

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

Cancer cell, 2017-02, Vol.31 (2), p.286-299

2017

Volltextzugriff (PDF)

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.523-535

2017

Volltextzugriff (PDF)

Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer

International journal of cancer, 2013-09, Vol.133 (5), p.1214-1221

2013

Volltextzugriff (PDF)

Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis

The lancet oncology, 2022-07, Vol.23 (7), p.931-939

2022

Volltextzugriff (PDF)

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction

iScience, 2022-12, Vol.25 (12), p.105487-105487, Article 105487

2022

Volltextzugriff (PDF)

Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts

Clinical cancer research, 2018-10, Vol.24 (20), p.5143-5152

2018

Volltextzugriff (PDF)

Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review

Seminars in cancer biology, 2022-11, Vol.86, p.521-542

2022

Volltextzugriff (PDF)

Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity

Cancer cell, 2021-08, Vol.39 (8), p.1115-1134.e12

2021

Volltextzugriff (PDF)

The Utility of Liquid Biopsies in Radiation Oncology

International journal of radiation oncology, biology, physics, 2020-08, Vol.107 (5), p.873-886

2020

Volltextzugriff (PDF)

CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.1308-1314

2024

Volltextzugriff (PDF)

Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre

Clinical and translational radiation oncology, 2021-09, Vol.30, p.43-49

2021

Volltextzugriff (PDF)

Epigenetic targeting of DNA repair in lung cancer

Proceedings of the National Academy of Sciences - PNAS, 2019-11, Vol.116 (45), p.22429-22431

2019

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(144)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(65)
Humans
(57)
Female
(35)
Oncology
(35)
Male
(34)
Middle Aged
(31)
Aged
(28)
Adult
(24)
Biological And Medical Sciences
(16)
Medical Sciences
(15)
Aged, 80 And Over
(14)
Cancer
(12)
Chemotherapy
(12)
Radiation Therapy
(11)
Radiotherapy
(11)
Radiology, Nuclear Medicine & Medical Imaging
(10)
Lung Cancer
(9)
Patients
(9)
Small Cell Lung Cancer
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Molecular Pathways: Understanding the Role of Rad52 in Homologous Recombination for Therapeutic Advancement

Target engagement imaging of PARP inhibitors in small-cell lung cancer

Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications

Radiation Therapy in the Molecular Era of Lung Cancer: How Best to Integrate Targeted Therapeutics With Definitive Radiation Therapy for Epidermal Growth Factor Receptor-Mutant Unresectable Stage III Non-Small Cell Lung Cancer?

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer

Limited-Stage Small-Cell Lung Cancer: Current Progress and the Next Frontier

Unravelling the biology of SCLC: implications for therapy

PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol

Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer

Intensity-Modulated Radiation Therapy in Oropharyngeal Carcinoma: Effect of Tumor Volume on Clinical Outcomes

PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches

A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer

Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction

Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts

Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review

Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity

The Utility of Liquid Biopsies in Radiation Oncology

CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer

Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre

Epigenetic targeting of DNA repair in lung cancer

Suchergebnisse filtern